Pioglitazone Improves Glucose Metabolism and Modulates Skeletal Muscle TIMP-3–TACE Dyad in Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Placebo-Controlled, Mechanistic Study

Diabetologia - Germany
doi 10.1007/s00125-013-2976-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Transglucosidase Improves the Bowel Movements in Type 2 Diabetes Mellitus Patients: A Preliminary Randomized Double-Blind, Placebo-Controlled Study

United European Gastroenterology Journal
OncologyGastroenterology
2017English

Propolis Supplementation Improves Glycemic and Antioxidant Status in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study

Complementary Therapies in Medicine
Alternative MedicineManual TherapySpecialized NursingAdvancedComplementary
2019English

Supplementation of Vitamin C Reduces Blood Glucose and Improves Glycosylated Hemoglobin in Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study

Advances in Pharmacological Sciences
ToxicologyMolecular MedicinePharmaceuticsPharmacology
2011English

Efficacy and Safety of Teneligliptin Added Onto Canagliflozin Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism
2018English

Probiotic Reduces Bacterial Translocation in Type 2 Diabetes Mellitus: A Randomised Controlled Study

Scientific Reports
Multidisciplinary
2017English

Probiotic Supplementation Improves Tolerance to Helicobacter Pylori Eradication Therapy - A Placebo-Controlled, Double-Blind Randomised Pilot Study

2006English

Does Working Memory Training Improve Dietary Self-Care in Type 2 Diabetes Mellitus? Results of a Double Blind Randomised Controlled Trial

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Effects of a Motilin Receptor Agonist (ABT-229) on Upper Gastrointestinal Symptoms in Type 1 Diabetes Mellitus: A Randomised, Double Blind, Placebo Controlled Trial

Gut
Gastroenterology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy